CVX Research Update — August 28, 2026
Updated Thesis
Chevron is a global integrated oil and gas company with large upstream, LNG, refining, marketing and U.S. shale operations, strengthened by Hess-related assets and a production base that reached 4.07 million boe/d in Q2 2026, up from 3.40 million boe/d a year earlier. Business quality is medium rather than high because its scale, integrated footprint, low-cost resource positions, cost-reduction program and disciplined $18-$19 billion 2026 organic-capex plan support cash generation, but commodity-set prices and capital intensity make earnings inherently cyclical.
The investment grade as of this refresh is C — average business quality. Medium-tier business, expensive-tier valuation, with 31.1% upside to $261.66 fair value but only 7.7% upside to the $215 consensus target.
Grade Change
In this research cycle, the investment grade for Chevron Corporation moved from D to C. Medium-tier business, expensive-tier valuation, with 31.1% upside to $261.66 fair value but only 7.7% upside to the $215 consensus target.
Key Metrics at a Glance
- Revenue growth: +51.4% year over year
- Net margin: 9.9%
- Fair value upside: +31.1% to our estimate of $262
Current price: $199.63
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Chevron Corporation remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full CVX research →](/stocks/CVX)